Acknowledgements

Project funding

Ensembl receives majority funding from the Wellcome Trust (grant number WT108749/Z/15/Z) with additional funding for specific project components from the National Human Genome Research Institute (U41HG007823 and 2U41HG007234), the Biotechnology and Biological Sciences Research Council (BB/N019563/1 and BB/M011615/1), Open Targets, the Wellcome Trust (WT104947/Z/14/Z, WT200990/Z/16/Z, WT201535/Z/16/Z, WT108749/Z/15/A, WT212925/Z/18/Z), ELIXIR: the research infrastructure for life-science data, and the European Molecular Biology Laboratory. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement n° 733161 (MultipleMS). We also receive funding from the 'Save the Tasmanian Devil Program'.

logo
Funded by Wellcome

logo

logo

logo

logo
Co-funded by the European Union

logo

logo

logo

Previous sources of funding

The Wellcome Trust Sanger Institute was a partner in the Ensembl project until 2016.

logo EU Framework Programme 6

logo

logo

logo

logo

logo

logo

logo

logo

logo

logo

logo

logo
The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement n° 282510 - BLUEPRINT.

Web image credits

  • All animal images on this site are public domain or used with permission of their creators. Please see our image credits page for full details.
  • The small icons used in the web interface are derived from the Rocky set by Icon Dock.
  • Project logos are used with permission of the relevant organisations
<p>On the 9th July tools (eg BLAST, VEP, etc) will be unavailable on this site for about 90 minutes starting at 1200 (UTC). This is needed for us to carry out essential maintenance. All other aspects of the site will be unnaffected. We apologise for any inconvenience this may cause.</p>